Vanguard Global Advisers
NUTX

Vanguard Global Advisers’s Nutex Health NUTX Stock Holding History

Vanguard Global Advisers’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$324K Sell
1,895
-1,118
-37% -$142K ﹤0.01% 2298
2026
Q1 		$286K Buy
+3,013
New +$370K ﹤0.01% 2267

Other funds holding NUTX

PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Winmill & Co Walpole, New Hampshire $452M AUM 56.84% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Vanguard Global Advisers's NUTX Position: Q2 2026 in Review

Vanguard Global Advisers reduced its Nutex Health (NUTX) stake by 37% in Q2 2026, selling an estimated $142K and leaving 1,895 shares worth $324K. The position accounts for ﹤0.01% of the portfolio, ranked #2298.

Vanguard Global Advisers first reported a position in NUTX in Q1 2026 and has held it in 2 quarters since. 152 funds tracked by Wall St. Rank hold NUTX as of Q2 2026.

  • Vanguard Global Advisers held 1,895 shares of Nutex Health worth $324K as of Q2 2026.
  • Vanguard Global Advisers sold 1,118 Nutex Health shares in Q2 2026, an estimated $142K.
  • Nutex Health made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #2298 holding.
  • Vanguard Global Advisers first reported a position in Nutex Health in Q1 2026 and has held it in 2 quarters since.
  • 152 funds tracked by Wall St. Rank held Nutex Health as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.